Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Standardized Microbiota Transplant Therapy in Crohn's Disease
NCT06631586Phase 2Recruiting
- Sponsor
- University of Minnesota
- Start
- Jan 2025
- Primary completion
- Jun 2029
- Modality
- Live Biotherapeutic Products
- Countries
- 1
01
Overview
Phase 2, randomised trial of MTP-101 and MTP-101S in Crohn's disease (2 arms), sponsored by University of Minnesota. Primary endpoint: Donor microbial engraftment at 2 months. Started Jan 2025; status: recruiting.
02
Drugs
MTP-101MTP-101S
03
Conditions
Crohn's disease
Beyond the preview
Go deeper on NCT06631586.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06631586.